Medicare Enrolled
Dr. Oscar Ortiz, M.D.
Optician · Toms River, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ortiz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ortiz?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ortiz
Dr. Oscar Ortiz is an optician specialist in Toms River, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Ortiz performed 4,263 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Ortiz received a total of $181,195 from 63 pharmaceutical and/or device companies across 1390 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ortiz is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 16% volume in NJ
$181,195 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗4,263
Medicare services
Top 16% in NJ for optician
Not available
Unique patients (not deduplicated)
$61
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,574 | $100 | $200 |
| Blood glucose test using hand-held instrument A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels. |
1,385 | $3 | $10 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
553 | $68 | $142 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
312 | $28 | $54 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
172 | $146 | $280 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
123 | $124 | $258 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
64 | $73 | $142 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
45 | $90 | $174 |
| Continuous glucose monitoring, sensor under skin This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin with provider-supplied equipment. |
19 | $118 | $265 |
| Continuous glucose monitoring, tissue fluid This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin. |
16 | $55 | $98 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$181,195
Total received (2018-2024)
Avg $25,885/year across 7 years
Top 1% in NJ for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
63
Companies
1,390
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$47,969
2023
$27,985
2022
$18,423
2021
$19,264
2020
$13,376
2019
$18,740
2018
$35,438
Payments by company (2024)
Lilly USA, LLC
$45,360
Novo Nordisk Inc
$297
Corcept Therapeutics
$274
Amneal Pharmaceuticals LLC
$270
SANOFI-AVENTIS U.S. LLC
$259
Dexcom, Inc.
$244
Medtronic, Inc.
$240
Boehringer Ingelheim Pharmaceuticals, Inc.
$221
Abbott Laboratories
$199
Bayer Healthcare Pharmaceuticals Inc.
$124
ABBVIE INC.
$106
PFIZER INC.
$61
Verity Pharmaceuticals Inc.
$51
AstraZeneca Pharmaceuticals LP
$39
Radius Health, Inc.
$36
Xeris Pharmaceuticals, Inc.
$29
Novartis Pharmaceuticals Corporation
$24
Insulet Corporation
$20
Mannkind Corporation
$19
Kyowa Kirin, Inc.
$17
IBSA Pharma Inc.
$16
Amgen Inc.
$16
Acella Pharmaceuticals, LLC
$16
Ascensia Diabetes Care Us Inc.
$15
OPKO Pharmaceuticals, LLC
$15
Top 3 companies account for 95.8% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$86,395
AstraZeneca Pharmaceuticals LP
$47,966
SANOFI-AVENTIS U.S. LLC
$28,885
Novo Nordisk Inc
$7,096
Abbott Laboratories
$1,063
Amneal Pharmaceuticals LLC
$996
Corcept Therapeutics
$981
Dexcom, Inc.
$677
Intuity Medical Inc
$650
Medtronic, Inc.
$628
Valeritas, Inc.
$496
Janssen Pharmaceuticals, Inc
$467
Boehringer Ingelheim Pharmaceuticals, Inc.
$392
Bayer Healthcare Pharmaceuticals Inc.
$373
Mannkind Corporation
$341
OPKO Pharmaceuticals, LLC
$242
MannKind Corporation
$212
Amgen Inc.
$195
IBSA Pharma Inc.
$194
ABBVIE INC.
$190
Merck Sharp & Dohme Corporation
$176
PFIZER INC.
$172
Horizon Therapeutics plc
$170
Kowa Pharmaceuticals America, Inc.
$167
DEXCOM, INC.
$165
Gemini Laboratories, LLC
$162
Insulet Corporation
$160
Bayer HealthCare Pharmaceuticals Inc.
$144
Medtronic MiniMed, Inc.
$130
Amarin Pharma Inc.
$112
Medtronic Vascular, Inc.
$104
Xeris Pharmaceuticals, Inc.
$102
Radius Health, Inc.
$97
AbbVie Inc.
$76
Becton, Dickinson and Company
$61
Verity Pharmaceuticals Inc.
$51
Aytu BioScience, Inc
$51
Antares Pharma, Inc.
$48
Endo Pharmaceuticals Inc.
$43
Alexion Pharmaceuticals, Inc.
$42
EISAI INC.
$41
Echosens North America, Inc.
$39
Amryt Pharma Holdings Ltd
$35
RECORDATI_RARE_DISEASES_INC.
$34
Kyowa Kirin, Inc.
$33
Tandem Diabetes Care, Inc.
$32
CeQur Corporation
$30
VIVUS, Inc.
$29
Nevro Corp.
$29
Currax Pharmaceuticals LLC
$24
Novartis Pharmaceuticals Corporation
$24
Acella Pharmaceuticals, LLC
$16
Supernus Pharmaceuticals, Inc.
$15
Ascensia Diabetes Care Us Inc.
$15
Shire North American Group Inc
$15
Ipsen Biopharmaceuticals, Inc
$15
Alfasigma USA, Inc.
$15
Ultragenyx Pharmaceutical Inc.
$15
Acerus Pharmaceuticals Corporation
$14
Regeneron Healthcare Solutions, Inc.
$14
Takeda Pharmaceuticals U.S.A., Inc.
$13
Eisai Inc.
$12
LifeScan, Inc.
$11
Top 3 companies account for 90.1% of all-time payments
Associated products mentioned in payments ›
AFREZZA · BAQSIMI · BD Nano · BD Nano 2nd Gen Pen Needle · BD Ultra-Fine · BOTOX · BYDUREON · Belviq · CONTRAVE · CeQur Simplicity · ClosureFast · Crysvita · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · EVENITY · EVERSENSE 365 SENSOR KIT (RETAIL) · EVKEEZA · FARXIGA · FIASP · FORTEO · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FibroScan · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre Pro · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · HUMALOG · HUMULIN · INPEN SMART INSULIN DELIVERY SYSTEM · INTELLIS ADAPTIVESTIM · INVOKANA · JANUVIA · JARDIANCE · Kerendia · Korlym · LEQVIO · LICART · LOKELMA · Lenvima · Livalo · MINIMED 770G · MINIMED 780G · MOUNJARO · MYALEPT · Macrilen · Minimed 630G · Minimed 670G System · NASCOBAL · NATPARA · NOCDURNA · NP Thyroid 60 · Natesto · OCTRODE · OT Verio Reflect "One Touch Meter and Strips" · Omnia · Omnipod · Ozempic · PREVNAR 20 · Pogo Automatic Blood Glucose Monitoring System · Prolia · QSYMIA · RAYALDEE · RECORLEV · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMATULINE DEPOT · SOMAVERT · STEGLATRO · SYNTHROID · Saxenda · Strensiq · Supera peripheral stent system · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tlando · Tresiba · Tymlos · UNITHROID · V-GO · Vascepa · Victoza · Wegovy · XARELTO · XYOSTED · ZEPBOUND · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Opticians in nearby ZIP areas
288
County median income
$86,411
Nearest hospital to ZIP centroid (approximate)
COMMUNITY MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ortiz is a clinical cardiology specialist, with above-average Medicare volume (top 16% in NJ), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ortiz experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Ortiz performed 1,574 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Ortiz receive payments from pharmaceutical companies?
Yes. Dr. Ortiz received a total of $181,195 from 63 companies across 1,390 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ortiz's costs compare to other opticians in Toms River?
Dr. Ortiz's average Medicare payment per service is $61. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ortiz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Toms River
Browse opticians in Toms River ranked by procedure volume and transparency data.
Highest volume
Top Opticians in NJ
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in NJ
Which NJ opticians receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
SANOFI-AVENTIS U.S. LLC Payments to Doctors
See all physicians who received payments from SANOFI-AVENTIS U.S. LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology